Serum malondialdehyde level: Surrogate stress marker in the Sikkimese diabetics

Journal of Natural Science, Biology and Medicine

Volumn 2, Issue 1, 2011, Pages 107-112

  Bhutia, Yazum ^a   Ghosh, Amrita ^a   Sherpa, Mingma L ^a   Pal, Ranabir ^a   Mohanta, Pradip Kumar ^b  

^a SIKKIM MANIPAL INSTITUTE OF MEDICAL SCIENCES   (India)

^b CALCUTTA NATIONAL MEDICAL COLLEGE   (India)

Author keywords

Glycated hemoglobin; Lipid peroxidation; Malondialdehyde; Type 2 diabetes mellitus

Indexed keywords

NICOTIANA TABACUM;

EID: 84876015737     PISSN: 09769668     EISSN: 22297707     Source Type: Journal    
DOI: 10.4103/0976-9668.82309     Document Type: Article

References (40)

1. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004; 24:816-23.
2. Chen J, Mehta JL. Role of oxidative stress in coronary heart disease. Indian Heart J 2004; 56: 163-73.
3. Likidlilid A, Patchanans N, Peerapatdit T, Sriratanasathavorn C. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients. J Med Assoc Thai 2010; 93: 682-93.
4. Su Y, Liu XM, Sun YM, Jin HB, Fu R, Wang YY, et al. The relationship between endothelial dysfunction and oxidative stress in diabetes and prediabetes. Int J Clin Pract 2008;62:877-82.
5. Wright E Jr, Scism-Bacon JL, Glass LC. Oxidative stress in type 2diabetes: The role of fasting and postprandial glycaemia. Int J Clin Pract 2006;60:308-14.
6. Newsholme P, Haber EP, Hirabara SM, Rebelato EL, Procopio J, Morgan D et al. Diabetes associated cell stress and dysfunction: Role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol 2007; 583: 9-24.
7. Palinski W, Ord VA, Plump AS, Breslow JL, Steinberg D, Witztum JL. ApoE-defi cient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specifi c epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb 1994;14:605-16.
8. Lazzarino G, Raatikainen P, Nuutinen M, Nissinen J, Tavazzi B, Pierro DD, et al. Myocardial release of malondialdehyde and purine compounds during coronary bypass surgery. Circulation 1994;90:291-7.
9. Kesavulu MM, Giri R, Kameswara Rao B, Apparao C. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab 2000;26:387-92.
10. Peerapatdit T, Patchanans N, Likidlilid A, Poldee S, Sriratanasathavorn C. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients. J Med Assoc Thai 2006;89:S147-55.
11. Bloomer RJ. Decreased blood antioxidant capacity and increased lipid peroxidation in young cigarett e smokers compared to nonsmokers: Impact of dietary intake. Nutrition Journal 2007; 6:39. Available from: http://www.nutritionj.com/content/6/1/39 [Last accessed 2010 on October 23].
12. Brownlee M, Cerami A, Viassara H. Advanced glycosylation end produts in tissue and the biochemical basis of diabetic complications. N Engl J Med 1998;318:1315-21.
13. Nakhjavani M, Esteghamati A, Nowroozi S, Asgarani F, Rashidi A, Khalilzadeh O. Type 2 diabetes mellitus duration: An independent predictor of serum malondialdehyde levels. Singapore Med J 2010;51:582-5.
14. Ohtsuki T, Malasumoto M, Suzuki K, Taniguchi N, Kadanada T. Mitochondrial lipid peroxidation and superoxide dismutase in rat hypertensive target organs. Am J Physiol 1995; 268: 1418-21.
15. Classifi cation and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 1979; 28: 1039-57.
16. World Health Organization. Second report of the WHO expert committ ee on diabetes. WHO Technical Report Series 646. Geneva, Switzerlan; 1980.
17. World Health Organization. Diabetes mellitus, report of a WHO study group. WHO Technical Report Series 727. Geneva, Switzerland; 1985
18. Dietrich M, Block G, Norkus EP, Hudes M, Traber MG, Cross CE, et al. Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase gamma-tocopherol in vivo aft er adjustment for dietary antioxidant intakes. Am J Clin Nutr 2003; 77: 160-6.
19. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen receptor. Ann Clin Biochem 1969; 6: 24-7.
20. Allian CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470-5.
21. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973; 19: 476-82.
22. Izzo C, Grlllo F, Murador E. Improved method for determination of high density lipoprotein cholesterol, I: Isolation of high density lipoprotein by use of polyethylene glycol 6000. Clin Chem 1981:27:371-4.
23. Warnick GR, Knopp RH, Fitzpatrick V, Branson L. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cut points. Clin Chem 1990;36:15-9.
24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
25. Konukoǧlu D, Akçay T, Dinçer Y, Hatemi H. The susceptibility of red blood cells to autoxidation in type 2 diabetic patients with angiopathy. Metabolism 1999; 48: 1481-4.
26. Volpi N, T arugi P. Improvement in the high-performance liquid chromatography malondialdehyde level determination in normal human plasma. J Chromatogr B Biomed Sci Appl 1998; 713: 433-7.
27. Ramakrishna V, Jailkhani R. Oxidative stress in non-insulindependent diabetes mellitus (NIDDM) patients. Acta Diabetol 2008; 45: 41-6.
28. Whiting PH, Kalansooriya A, Holbrook I, Haddad F, Jennings PE. The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus. Br J Biomed Sci 2008;65:71-4.
29. Hanachi P, Moghadam RH, Latiff ah AL. Investigation of Lipid Profi les and Lipid Peroxidation in patients with Type 2 Diabetes. Eur J Sci Res 2009; 28: 6-13.
30. Kalaivanam KN, Dharmalingam M, Marcus SR. Lipid peroxidation in type 2 diabetes mellitus. Int J Diabetes Dev Ctries 2006;26:30-2.
31. Surekha Rani H, Madhavi G, Ramachandra Rao V, Sahay BK, Jyothy A. Risk factors for coronary heart disease in type II diabetes Mellitus. Indian J Clin Biochem 2005;20:75-80.
32. Reshamwala SM, Patil ND. Biochemical changes in erythrocytemembrane in uncontrolled type 2 diabetes mellitus. I ndian J Biochem Biophys 2005;42:250-3.
33. Sundaram RK, Bhaskar A, Vijayalingam S. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci 1996;90:255-60.
34. Domínguez C, Ruiz E, Gussinye M. Oxidative Stress at Onset and in Early Stages of Type 1 Diabetes in Children and Adolescents. Diabetes Care 1998;21:1736-42.
35. Soliman GZ. Blood lipid peroxidation (superoxide dismutase, malondialdehyde, glutathione) levels in Egyptian type 2 diabetic patients. Singapore Med J 2008;49:129-36.
36. Pasaoglu H, Sancak B, Bukan N. Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus. Tohoku J Exp Med 2004;203:211-8.
37. Gupta M, Suresh Chari S. Proxidant and antioxidant status in patients of type II Diabetes Mellitus with IHD. Indian J Clin Biochem 2006;21:118-22.
38. Pan H Z, Zhang H, Chang D, Li H, Sui H. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol 2008;92:548-51.
39. Ozdemir G, Ozden M, Maral H, Kuskay S, Cetinalp P, Tarkun I. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria. Ann Clin Biochem 2005;42:99-104.
40. Kumawat M, Pahwa MB, Gahlaut VS, Singh N. Stat us of Antioxidant Enzymes and Lipid Peroxidation in Type 2 Diabetes Mellitus with Micro Vascular Complications. Open Endocrinol J 2009;3:12-5.